• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 339-353 of 1,170 results

2007 Exhibit: File History of US Patent 10,130,681

Document IPR2022-01524, No. 2007 Exhibit - File History of US Patent 10,130,681 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2008 Exhibit: File History of US Patent 10,857,205 Part 3 of 7

Document IPR2022-01524, No. 2008-3 Exhibit - File History of US Patent 10,857,205 Part 3 of 7 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2008 Exhibit: File History of US Patent 10,857,205 Part 1 of 7

Document IPR2022-01524, No. 2008 Exhibit - File History of US Patent 10,857,205 Part 1 of 7 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2008 Exhibit: File History of US Patent 10,857,205 Part 4 of 7

Document IPR2022-01524, No. 2008-4 Exhibit - File History of US Patent 10,857,205 Part 4 of 7 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2018 Exhibit: Dec 12 2022 Letter to Neil B McLaughlin from Thomas S Fletcher Reg...

Document IPR2022-01524, No. 2018 Exhibit - Dec 12 2022 Letter to Neil B McLaughlin from Thomas S Fletcher Regarding Narrowing the Case, Mylan Pharms Inc v Regeneron Pharms, Inc, Case No 122 cv...

cite Cite Document
Analyze

2016 Exhibit: Regeneron’s Response to Mylan’s Post Hearing Supplement, Regen...

Document IPR2022-01524, No. 2016 Exhibit - Regeneron’s Response to Mylan’s Post Hearing Supplement, Regeneron Pharms, Inc v Mylan Pharms Inc, Case No 122 cv 00061 TSK (P.T.A.B. Dec. 23, 202...

cite Cite Document
Analyze

2008 Exhibit: File History of US Patent 10,857,205 Part 5 of 7

Document IPR2022-01524, No. 2008-5 Exhibit - File History of US Patent 10,857,205 Part 5 of 7 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2029 Exhibit: Petition for Inter Partes Review of US Patent No 9,669,069 B2, Mylan...

Document IPR2022-01524, No. 2029 Exhibit - Petition for Inter Partes Review of US Patent No 9,669,069 B2, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00880 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2008 Exhibit: File History of US Patent 10,857,205 Part 7 of 7

Document IPR2022-01524, No. 2008-7 Exhibit - File History of US Patent 10,857,205 Part 7 of 7 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2020 Exhibit: Jaffe et al, Differential Response to Anti VEGF Regimens in Age Rela...

Document IPR2022-01524, No. 2020 Exhibit - Jaffe et al, Differential Response to Anti VEGF Regimens in Age Related Macular Degeneration Patients with Early Persistent Retinal Fluid, 123 OPHTHALMOL...

cite Cite Document
Analyze

2025 Exhibit: Mansour et al, Long term Visual Outcomes of Intravitreal Bevacizuma...

Document IPR2022-01524, No. 2025 Exhibit - Mansour et al, Long term Visual Outcomes of Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization, 148 AM J OPTHAMOLOGY 310 2009 (P.T...

cite Cite Document
Analyze

2027 Exhibit: Motion Requesting Expedited Status Conference, Regeneron Pharm...

Document IPR2022-01524, No. 2027 Exhibit - Motion Requesting Expedited Status Conference, Regeneron Pharms, Inc v Mylan Pharms Inc, Case No 122 cv 00061 TSK (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2021 Exhibit: Expert Declaration of Lucian V Del Priore, MD, PhD Redacted Copy, M...

Document IPR2022-01524, No. 2021 Exhibit - Expert Declaration of Lucian V Del Priore, MD, PhD Redacted Copy, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00881, Exhibit No 2048 (P.T.A.B. D...

cite Cite Document
Analyze

2003 Exhibit: Decision, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 0088...

Document IPR2022-01524, No. 2003 Exhibit - Decision, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00881 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2026 Exhibit: Lott et al, Bevacizumab in Inflammatory Eye Disease, 148 AM J OPTH...

Document IPR2022-01524, No. 2026 Exhibit - Lott et al, Bevacizumab in Inflammatory Eye Disease, 148 AM J OPTHAMOLOGY 711 2009 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 23 24 25 26 27 ... >>